Cornell Medicine professor and Akelos Inc. scientific founder secures nearly $2M in NIH funding to develop nonaddictive, non-opioid chronic pain treatment New York, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Akelos Inc., a biotechnology company currently developing and commercializing a non-opioid, anti-hyperalgesic drug to treat chronic and neuropathic pain,...